Skip to content
Bored Studies
RecruitingPhase 4

SUMMIT RISE Study of Acute Ischemic Stroke Patients

Route 92 Medical, Inc. · NCT07436156

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 4
Target enrollment
500
US sites recruiting
1
Study start
February 12, 2026
Record last updated
February 27, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

SUMMIT RISE Study of Acute Ischemic Stroke Patients

Being studied: Route 92 Medical Reperfusion Systems

Conditions: Acute Ischemic Stroke

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Acute ischemic stroke patient initially treated (first pass) with a Route 92 Medical Reperfusion System
  • Informed consent completed and documented within 72 hours following thrombectomy procedure
  • Endovascular treatment initiated (defined as time of groin puncture) within 8 hours from time last known well
  • Age ≥ 18 years

Exclusion Criteria

  • None

Recruiting US locations

  • Route 92 Medical, Inc.

    West Jordan, UT 84088

    Site contact: Renee Kochevar Vice President, Clinical Research, PhD, ALM · 650-581-1179 · reneek@r92m.com

Study contacts (from the official record)

  • Renee Kochevar Vice President, Clinical Research, PhD, ALM · 650-581-1179 · reneek@r92m.com
All neurology studies in Utah →
SUMMIT RISE Study of Acute Ischemic Stroke Patients (NCT07436156) | Bored Studies